The impact of a dose of the angiotensin receptor blocker valsartan on post‐myocardial infarction ventricular remodelling
K Park, YD Kim, KS Kim, SH Lee, TH Park… - ESC Heart …, 2018 - Wiley Online Library
Aims Although clinical guidelines advocate the use of the highest tolerated dose of
angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers after acute …
angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers after acute …
The impact of dose of the angiotensin-receptor blocker valsartan on the post-myocardial infarction ventricular remodeling: study protocol for a randomized controlled …
YR Cho, YD Kim, TH Park, K Park, JS Park, H Baek… - Trials, 2011 - Springer
Background Angiotensin-converting enzyme inhibitors and the angiotensin-receptor blocker
valsartan ameliorate ventricular remodeling after myocardial infarction (MI). Based on …
valsartan ameliorate ventricular remodeling after myocardial infarction (MI). Based on …
Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction
SD Solomon, H Skali, NS Anavekar, M Bourgoun… - Circulation, 2005 - Am Heart Assoc
Background—Angiotensin-converting enzyme (ACE) inhibitors have been shown to
attenuate left ventricular (LV) enlargement in association with reducing mortality after …
attenuate left ventricular (LV) enlargement in association with reducing mortality after …
Effects of enalapril and losartan in left ventricular remodeling after acute myocardial infarction: a possible mechanism of prevention of cardiac events by angiotensin …
S Tani, K Nagao, T Anazawa, H Kawamata… - Internal …, 2009 - jstage.jst.go.jp
Background Angiotensin-converting enzyme inhibitors (ACE-I) and angiotensin II receptor
blockers (ARB) have been shown to have a significant cardioprotective effect in high-risk …
blockers (ARB) have been shown to have a significant cardioprotective effect in high-risk …
[HTML][HTML] Effect of angiotensin II type 1 receptor antagonist valsartan on cardiac remodeling and left ventricular function in patients with acute ST-elevation myocardial …
O Eduard, S Crina, D Smaranda - Journal of Medicine and Life, 2008 - ncbi.nlm.nih.gov
Background: Left ventricular (LV) remodeling after acute ST-elevation myocardial infarction
(STEMI) is an important predictor of mid and long-term prognosis. Pathological cardiac …
(STEMI) is an important predictor of mid and long-term prognosis. Pathological cardiac …
Inhibitory Effect of Valsartan Against Progression of Left Ventricular Dysfunction After Myocardial Infarction T-VENTURE Study
H Suzuki, E Geshi, S Nanjyo, H Nakano… - Circulation …, 2009 - jstage.jst.go.jp
Background: Angiotensin-converting enzyme inhibitors (ACEI) reduce the mortality in the
chronic phase of myocardial infarction (MI), and similar effects of angiotensin receptor …
chronic phase of myocardial infarction (MI), and similar effects of angiotensin receptor …
Enalapril suppresses ventricular remodeling more effectively than losartan in patients with acute myocardial infarction
H Onodera, T Matsunaga, Y Tamura, N Maeda… - American Heart …, 2005 - Elsevier
BACKGROUND: Ventricular remodeling after acute myocardial infarction (AMI) is associated
with increased morbidity and mortality. ELITE II study showed that losartan, an angiotensin …
with increased morbidity and mortality. ELITE II study showed that losartan, an angiotensin …
Effects of losartan and captopril on left ventricular systolic and diastolic function after acute myocardial infarction: results of the Optimal Trial in Myocardial Infarction …
JE Møller, U Dahlström, O Gøtzsche, A Lahiri… - American Heart …, 2004 - Elsevier
BACKGROUND: Angiotensin-converting enzyme inhibitors have been shown to attenuate
adverse remodeling after acute myocardial infarction (AMI), and the same has been …
adverse remodeling after acute myocardial infarction (AMI), and the same has been …
Rationale and design of a multi‐center, prospective randomized controlled trial on the effects of sacubitril–valsartan versus enalapril on left ventricular remodeling in …
K Diao, D Wang, Z Chen, X Wu, M Ma, Y Zhu… - Clinical …, 2021 - Wiley Online Library
Background Angiotensin receptor neprilysin inhibitor (ARNI) sacubitril‐valsartan has been
recommended as one of the first‐line therapies in heart failure with reduced ejection fraction …
recommended as one of the first‐line therapies in heart failure with reduced ejection fraction …
Impact of sacubitril/valsartan compared with ramipril on cardiac structure and function after acute myocardial infarction: the PARADISE-MI echocardiographic substudy
AM Shah, B Claggett, N Prasad, G Li, M Volquez… - Circulation, 2022 - Am Heart Assoc
Background: Angiotensin-converting enzyme inhibitors attenuate left ventricular (LV)
enlargement after acute myocardial infarction (AMI). Preclinical data suggest similar benefits …
enlargement after acute myocardial infarction (AMI). Preclinical data suggest similar benefits …